Julie A. Crawford
Keine laufenden Positionen mehr
Profil
Julie A.
Crawford worked as a Director of Finance & Administration at Salmedix, Inc. and Palkion, Inc. She was also a Director of Finance & Administration at Aires Pharmaceuticals, Inc. from 2007 to 2011.
Prior to that, she worked as a Principal at Corvas International, Inc. from 1987 to 1995.
She also worked as a Consultant at Canji, Inc. from 1999 to 2000 and at Cabrellis Pharmaceuticals Corp.
in 2006.
Ms. Crawford holds an MBA from The University of Chicago and an undergraduate degree from the University of Wisconsin.
Ehemalige bekannte Positionen von Julie A. Crawford
| Unternehmen | Position | Ende |
|---|---|---|
Cabrellis Pharmaceuticals Corp.
 Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Corporate Officer/Principal | - |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Finanzdirektor/CFO | - |
| Corvas International, Inc. | Corporate Officer/Principal | 01.01.1995 |
Canji, Inc.
 Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Corporate Officer/Principal | 01.01.2000 |
Palkion, Inc.
 Palkion, Inc. Pharmaceuticals: MajorHealth Technology Palkion, Inc. manufactured pharmaceutical products for the treatment of anemia. The company was founded in February 2008 and was headquartered in San Diego, CA. | Finanzdirektor/CFO | - |
Ausbildung von Julie A. Crawford
| The University of Chicago | Masters Business Admin |
| University of Wisconsin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Aires Pharmaceuticals, Inc.
 Aires Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Aires Pharmaceuticals, Inc. develops drugs to treat pulmonary disorders. It offers Aironite, an inhaled drug that is used to treat adult and pediatric pulmonary hypertension, cystic fibrosis, pneumonia and other respiratory infections. The company was founded by Wendy S. Johnson in 2006 and is headquartered in San Diego, CA. | Health Services |
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Cabrellis Pharmaceuticals Corp.
Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Health Technology |
| Corvas International, Inc. | Health Technology |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Health Services |
Palkion, Inc.
Palkion, Inc. Pharmaceuticals: MajorHealth Technology Palkion, Inc. manufactured pharmaceutical products for the treatment of anemia. The company was founded in February 2008 and was headquartered in San Diego, CA. | Health Technology |